Swedish
Investerare
Aktieägare
EQT logo
Om
Medarbetare
Hållbarhet
Investeringar
Media
Current portfolio
Arvelle Therapeutics
Dutch biotech company commercializing an epilepsy drug with unprecedented efficacy for refractory patients with partial onset seizures.
Sektor
Healthcare
Land
Netherlands
Fond
LSP 6
Entry
2019
Web
arvelletx.com
Sektor
Healthcare
Land
Netherlands
Fond
LSP 6
Entry
2019
Web
arvelletx.com
Investments
EQT logo